Journal article
Isoniazid preventive therapy added to ART to prevent TB: an individual participant data meta-analysis
- Abstract:
-
Background: Isoniazid preventive therapy prevents active tuberculosis in people with HIV, but previous studies have found no evidence of benefit in people with HIV who had a negative tuberculin skin test, and a non-significant effect on mortality. We aimed to estimate the effect of isoniazid preventive therapy given with antiretroviral therapy (ART) for the prevention of tuberculosis and death among people with HIV across population subgroups.
Methods:
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 1.0MB, Terms of use)
-
- Publisher copy:
- 10.1016/S2352-3018(20)30299-X
Authors
- Publisher:
- Elsevier
- Journal:
- Lancet HIV More from this journal
- Volume:
- 8
- Issue:
- 1
- Pages:
- E8-E15
- Publication date:
- 2021-01-01
- Acceptance date:
- 2020-10-14
- DOI:
- EISSN:
-
2352-3018
- ISSN:
-
2405-4704
- Language:
-
English
- Keywords:
- Pubs id:
-
1138057
- Local pid:
-
pubs:1138057
- Deposit date:
-
2020-10-17
- ARK identifier:
Terms of use
- Copyright holder:
- Elsevier
- Copyright date:
- 2020
- Rights statement:
- © 2020 Elsevier Ltd. All rights reserved.
- Notes:
- This is the accepted manuscript version of the article. The final version is available from Elsevier at: https://doi.org/10.1016/S2352-3018(20)30299-X
If you are the owner of this record, you can report an update to it here: Report update to this record